Abstract
BACKGROUND: Pterygium is a degenerative disorder of the conjunctiva characterized by a high recurrence rate. Currently, Sulfacrylate adhesive is used in various medical fields to reduce surgery time and improve the treatment effectiveness. For pterygium treatment, the resorption rate of the adhesive film and its ability to completely resorb are important. To objectively monitor this process and the eye mucosa condition, ultrasound biomicroscopy should be used. AIM: The study aimed to perform clinical ultrasound monitoring of the results of pterygium surgery using Sulfacrylate medical adhesive. METHODS: A single-center, uncontrolled clinical study involved patients with recurrent and active primary pterygium. All the participants underwent surgery which included resection of pterygium and conjunctival autograft transplantation with graft fixation using Sulfacrylate medical adhesive. Follow-up was performed on postoperative days 3 and 7, at weeks 3, 6, 12, and month 18. Ultrasound biomicroscopy was performed in all patients at postoperative week 3 and months 6 and 12 to objectively assess changes in the sulfacrylate adhesive layer over time. RESULTS: The clinical study included 5 patients (5 eyes) aged 30 to 50 years with diagnosed pterygium. A week after surgery, complete epithelialization of the defect was achieved in all patients. By month 6 of follow-up, complete engraftment of the transplanted conjunctival flap was observed. Ultrasound biomicroscopy confirmed resorption of the adhesive film used to fix the flap. Examination at postoperative months 12 and 18 revealed no cases of pterygium recurrence. CONCLUSION: Sulfacrylate medical adhesive is promising in pterygium surgery to prevent relapses during a 18-month follow-up. Ultrasound biomicroscopy is highly effective in postoperative assessment of the anterior segment tissues after pterygium surgery.